Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Jupiter Neurosciences Inc. (JUNS:NASDAQ), powered by AI.
Jupiter Neurosciences Inc. is currently trading at $0.15. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Jupiter Neurosciences Inc. on Alpha Lenz.
Jupiter Neurosciences Inc.'s P/E ratio is -0.6.
“Jupiter Neurosciences Inc. trades at a P/E of -0.6 (undervalued) with modest ROE of -738.8%.”
Ask for details →Jupiter Neurosciences Inc. is a biotech company dedicated to advancing innovative treatments in the field of neuroscience. The company focuses on the development of therapies that address central nervous system disorders, which may include debilitating conditions such as Alzheimer's disease, multiple sclerosis, and other neurodegenerative diseases. By leveraging cutting-edge research and development, Jupiter Neurosciences aims to create novel pharmaceutical solutions that can significantly improve the quality of life for patients affected by neurological challenges. The firm's work is particularly impactful within the biotechnology and pharmaceutical industries as it targets a critical area of healthcare with a growing demand for effective treatment options. As a player in the biotech sector, Jupiter Neurosciences often engages in clinical trials and collaborates with other research institutions to push the boundaries of current medical understanding and therapies. Its presence in the market underscores the importance of innovation in addressing complex health issues that have extensive impacts on patients and healthcare systems worldwide.
“Jupiter Neurosciences Inc. trades at a P/E of -0.6 (undervalued) with modest ROE of -738.8%.”
Ask for details →Jupiter Neurosciences Inc. (ticker: JUNS) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 4 employees. Market cap is $5M.
The current price is $0.153 with a P/E ratio of -0.61x and P/B of -2.89x.
ROE is -738.83% and operating margin is -40873.19%. Annual revenue is $21,796.